Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC N-[4-[2-(5-chloro-2-methoxy-4-pyrimidinyl)ethyl]-2-thiazolyl]-2-(trifluoromethyl)-4-pyridinesulfonam | 1788872-06-9 | >98.0% | 430.95 g/mol | C17H20ClFN4O2S2 | 50 MG
SDP

Catalog No. 5000248666
Encompass_Preferred

Nav1.7-IN-3 is a selective, orally bioavailable small-molecule inhibitor of the voltage-gated sodium channel Nav1.7 (IC50 ≈ 8 nM) developed for neuroscience research into pain mechanisms. It shows limited central nervous system penetration and is supplied as a research reagent for in vivo and in vitro studies.

  • Selective Nav1.7 inhibition with IC50 ≈ 8 nM.
  • Orally bioavailable, suitable for oral dosing studies.
  • Limited central nervous system penetration.
  • Provided as a solid for formulation and dosing flexibility.
  • Characterized by CAS 1788872-06-9 and molecular weight 430.95 g/mol.

Catalog No. 50-002-48666 Supplier Medchemexpress LLC Supplier No. HY10178950MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Nav1.7-IN-3 is a selective, orally bioavailable small-molecule inhibitor of the voltage-gated sodium channel Nav1.7 (IC50 ≈ 8 nM) developed for neuroscience research into pain mechanisms. It shows limited central nervous system penetration and is supplied as a research reagent for in vivo and in vitro studies.

  • Selective Nav1.7 inhibition with IC50 ≈ 8 nM.
  • Orally bioavailable, suitable for oral dosing studies.
  • Limited central nervous system penetration.
  • Provided as a solid for formulation and dosing flexibility.
  • Characterized by CAS 1788872-06-9 and molecular weight 430.95 g/mol.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.